TipRanks
Xvivo Perfusion AB (DE:3XV)
FRANKFURT:3XV
Germany Market
3XV
Xvivo Perfusion AB
RESEARCH TOOLSreports

Xvivo Perfusion AB (3XV) Ratios

0 Followers

Xvivo Perfusion AB Ratios

DE:3XV's free cash flow for Q2 2026 was kr0.63. For the 2026 fiscal year, DE:3XV's free cash flow was decreased by kr and operating cash flow was kr0.09. See a summary of the company’s cash flow.
Ratios
TTM
Dec 25Dec 24Dec 23Dec 22
Liquidity Ratios
Current Ratio
 3.86 5.77 4.58 6.14 3.47
Quick Ratio
 2.65 3.68 3.30 5.09 2.68
Cash Ratio
 1.62 2.45 2.34 4.06 1.83
Solvency Ratio
 0.49 0.37 0.97 0.49 0.11
Operating Cash Flow Ratio
 1.25 0.85 0.63 0.34 0.21
Short-Term Operating Cash Flow Coverage
 20.21 0.00 0.00 0.00 0.00
Net Current Asset Value
kr 402.21Mkr 427.56Mkr 567.11Mkr 575.84Mkr 164.56M
Leverage Ratios
Debt-to-Assets Ratio
 0.05 0.05 0.01 0.01 <0.01
Debt-to-Equity Ratio
 0.06 0.06 0.02 0.02 <0.01
Debt-to-Capital Ratio
 0.05 0.06 0.02 0.02 <0.01
Long-Term Debt-to-Capital Ratio
 0.05 0.00 0.00 0.00 0.00
Financial Leverage Ratio
 1.15 1.12 1.11 1.13 1.21
Debt Service Coverage Ratio
 28.13 3.15 43.78 27.18 32.29
Interest Coverage Ratio
 -16.98 2.10 15.77 3.52 21.19
Debt to Market Cap
 0.02 0.00 0.00 0.00 0.00
Interest Debt Per Share
 3.65 5.37 1.26 1.09 0.38
Net Debt to EBITDA
 -1.00 -1.09 -1.40 -14.67 -6.03
Profitability Margins
Gross Profit Margin
62.85%65.69%74.95%74.49%71.51%
EBIT Margin
12.63%10.21%24.99%0.70%5.64%
EBITDA Margin
20.57%18.86%33.19%5.87%9.44%
Operating Profit Margin
12.66%11.45%10.74%0.70%5.58%
Pretax Profit Margin
14.69%4.75%24.31%15.82%5.37%
Net Profit Margin
9.89%3.10%20.94%15.37%4.44%
Continuous Operations Profit Margin
9.89%3.10%20.94%15.37%4.44%
Net Income Per EBT
67.35%65.26%86.11%97.14%82.58%
EBT Per EBIT
116.04%41.46%226.31%2257.49%96.26%
Return on Assets (ROA)
3.51%1.06%7.17%4.18%1.06%
Return on Equity (ROE)
4.13%1.19%7.98%4.72%1.29%
Return on Capital Employed (ROCE)
4.85%4.13%3.97%0.20%1.45%
Return on Invested Capital (ROIC)
3.25%2.68%3.40%0.20%1.19%
Return on Tangible Assets
9.17%2.72%17.30%9.42%3.32%
Earnings Yield
1.15%0.43%1.12%0.93%0.34%
Efficiency Ratios
Receivables Turnover
 4.57 5.50 6.22 6.09 4.16
Payables Turnover
 1.88 8.85 5.22 4.23 3.08
Inventory Turnover
 1.46 1.12 0.91 1.08 1.11
Fixed Asset Turnover
 4.10 3.80 5.52 6.13 8.73
Asset Turnover
 0.35 0.34 0.34 0.27 0.24
Working Capital Turnover Ratio
 1.62 1.35 1.24 1.17 1.07
Cash Conversion Cycle
 135.59 350.53 391.66 312.68 297.77
Days of Sales Outstanding
 79.92 66.36 58.64 59.94 87.73
Days of Inventory Outstanding
 250.06 325.43 402.93 339.07 328.70
Days of Payables Outstanding
 194.39 41.26 69.90 86.33 118.66
Operating Cycle
 329.98 391.79 461.56 399.01 416.43
Cash Flow Ratios
Operating Cash Flow Per Share
 7.50 3.21 3.53 1.55 0.94
Free Cash Flow Per Share
 6.08 -4.82 -2.60 -3.26 -3.49
CapEx Per Share
 4.18 3.21 6.13 1.44 4.43
Free Cash Flow to Operating Cash Flow
 0.81 -1.50 -0.74 -2.11 -3.70
Dividend Paid and CapEx Coverage Ratio
 1.79 1.00 0.58 1.08 0.21
Capital Expenditure Coverage Ratio
 1.79 1.00 0.58 1.08 0.21
Operating Cash Flow Coverage Ratio
 1.94 0.81 3.27 1.47 2.78
Operating Cash Flow to Sales Ratio
 0.26 0.12 0.14 0.08 0.07
Free Cash Flow Yield
2.48%-2.58%-0.53%-0.99%-1.91%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
 87.33 233.25 89.40 107.42 293.22
Price-to-Sales (P/S) Ratio
 8.63 7.24 18.73 16.51 13.01
Price-to-Book (P/B) Ratio
 3.51 2.78 7.14 5.07 3.78
Price-to-Free Cash Flow (P/FCF) Ratio
 40.35 -38.71 -188.16 -101.01 -52.41
Price-to-Operating Cash Flow Ratio
 32.71 58.16 138.41 213.10 193.97
Price-to-Earnings Growth (PEG) Ratio
 -4.23 -2.73 1.14 0.27 2.41
Price-to-Fair Value
 3.51 2.78 7.14 5.07 3.78
Enterprise Value Multiple
 40.98 37.29 55.03 266.74 131.77
Enterprise Value
 7.55B 5.71B 15.02B 9.35B 5.17B
EV to EBITDA
 40.98 37.29 55.03 266.74 131.77
EV to Sales
 8.43 7.03 18.27 15.65 12.44
EV to Free Cash Flow
 39.40 -37.61 -183.50 -95.74 -50.12
EV to Operating Cash Flow
 31.93 56.50 134.98 201.99 185.48
Tangible Book Value Per Share
 20.31 21.05 23.79 24.21 8.53
Shareholders’ Equity Per Share
 69.85 67.10 68.47 64.98 48.44
Tax and Other Ratios
Effective Tax Rate
 0.33 0.35 0.14 0.03 0.17
Revenue Per Share
 28.42 25.78 26.11 19.96 14.07
Net Income Per Share
 2.81 0.80 5.47 3.07 0.62
Tax Burden
 0.67 0.65 0.86 0.97 0.83
Interest Burden
 1.16 0.46 0.97 22.57 0.95
Research & Development to Revenue
 0.13 0.12 0.18 0.23 0.17
SG&A to Revenue
 0.44 0.46 0.46 0.13 0.17
Stock-Based Compensation to Revenue
 0.00 0.00 0.00 <0.01 0.00
Income Quality
 2.67 4.02 0.56 0.50 1.25
Currency in SEK